| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $611.3M | $144.2M | $136.6M |
| YoY Revenue Growth % | +324.0% | +5.5% | — |
| Gross Profit | $214.5M | -$72.6M | — |
| Gross Margin % | 35.1% | -50.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$236.5M | -$72.2M | -$98.3M |
| Operating Margin % | -38.7% | -50.1% | -72.0% |
| Net Income (GAAP) | -$250.3M | -$233.7M | -$149.3M |
| EBITDA (Normalized) | -$214.5M | -$67.0M | -$93.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $89.7M | -$115.4M | $13.8M |
| Capital Expenditures (CapEx) | $27.5M | $6.5M | $6.1M |
| Free Cash Flow (FCF) | $62.2M | -$121.9M | $7.6M |
| FCF Margin % | 10.2% | -84.5% | 5.6% |
| Return on Invested Capital (ROIC %) | -19.5% | -9.2% | -4.0% |
| Cash & Short-Term Equivalents | $1.91B | $286.2M | — |
| Total Debt (Short + Long Term) | $1.42B | $473.8M | $755.4M |
| Total Stockholders' Equity | $1.45B | $434.6M | $1.55B |